Overview & Mission
At Evidera, we are dedicated to helping you optimize the value and market access of your products.
In partnership with you, our scientists and consultants:
- Utilize insights from patients, payers, HTA bodies, regulators, providers and other stakeholders to inform value demonstration strategies
- Develop, capture, and effectively communicate the required evidence
- Bring world-class science, methodological expertise and thought leadership to everything we do
Evidera provides health economics, outcomes research, market access, data analytics and epidemiology services. We partner with life sciences organizations worldwide to optimize the market access and commercial success of their products by leveraging our unparalleled knowledge of the global payer and regulator landscape and by developing, capturing and communicating the clinical and economic evidence that our clients require to successfully market their products. Our research and consulting services are driven by world-class science and thought leadership and leverage a unique combination of capabilities.
Our staff are methodological leaders and innovators that have pioneered new methods of simulation modeling, created a consortium initiative which led to the development of one accepted PRO in the area of COPD, developed PRO dossiers, guided thought leadership in the areas of Bayesian statistics and comparative effectiveness, and invented the SAVIOR(®) methodology for payer research. Over 20% of our scientists have more than 15 years of experience, and approximately 75% holding advanced degrees (e.g., MD, PhD, Masters). Staff are frequently featured as keynote speakers at industry events and have authored over 2,000 peer-reviewed publications.
Assets and relationships
Our staff have successfully interacted with payers and health authorities in many markets (e.g., FDA, EMA, NICE, GBA), forging relationships that are invaluable in being able to provide actionable, insightful guidance. In addition, we maintain one of the largest networks of payers and HTA bodies in the world, allowing for rapid, relevant payer input on behalf of clients.
Breadth and depth of capabilities
Evidera is home to the largest global health economics group and is one of the largest providers of outcomes research, epidemiology and payer/market access consulting. Having all of these capabilities in house provides the ability to partner with life sciences companies as early as Phase II to develop their value strategy and then continue to work with them across the product life cycle to ensure the appropriate evidence is developed to maximize the value of the product.
According to a 2009 survey by a leading global management consulting firm, our Health Economics, Outcomes Research and Market Access groups are viewed by biopharmaceutical companies as the best in the industry along all metrics measured, including quality, ability to execute, technical capabilities, relationships, therapeutic expertise and overall reputation.
We are headquartered in Bethesda, Maryland, with primary offices in Massachusetts and the United Kingdom, and additional offices in Washington State, Canada and Hungary. Our staff have expertise working in all developed and most developing countries.